Balyasny Asset Management »

Entrada Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $144k 14k 10.28
2022-12-31 $164k 12k 13.52

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Tesla Motors Call Option (TSLA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr State Street Fin (XLF)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Vaneck Etf Trust Semiconductr Etf (SMH)
Broadcom Put Option (AVGO)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)

View all positions for Balyasny Asset Management

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
5AM Venture Management
BlackRock
TCG Crossover Management
Vanguard Group
Wellington Management Company
StepStone
Geode Capital Management
State Street Corporation
Millennium Management
Jacobs Levy Equity Management
Acadian Asset Management
Citadel Advisors
Dimensional Fund Advisors
Renaissance Technologies

View all funds holding Entrada Therapeutics